Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy

Michael H Olsen, Kristian Wachtell, Hans Ibsen, Lars Lindholm, Sverre E Kjeldsen, Per Omvik, Markku S Nieminen, Björn Dahlöf, Peter M Okin, Richard B Devereux

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

To investigate whether in-treatment measurements of subclinical organ damage (SOD) assessed by elevated urine albumin/creatinine ratio (UACR) or electrocardiographic left ventricular hypertrophy improved the prediction of the composite cardiovascular endpoint of cardiovascular death, nonfatal myocardial infarction and stroke beyond in-treatment Framingham risk score (FRS).
Original languageEnglish
JournalInternational Journal of Hypertension
Volume29
Issue number5
Pages (from-to)997-1004
Number of pages8
ISSN2090-0392
DOIs
Publication statusPublished - 2011

Keywords

  • Aged
  • Aged, 80 and over
  • Antihypertensive Agents
  • Cardiovascular Diseases
  • Echocardiography
  • Female
  • Humans
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Risk Assessment
  • Risk Reduction Behavior

Fingerprint

Dive into the research topics of 'Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy'. Together they form a unique fingerprint.

Cite this